Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-03-05 @ 4:33 AM
Study NCT ID:
NCT01873833
Status:
TERMINATED
Last Update Posted:
2023-10-05
First Post:
2013-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Sponsor:
University of Southern California
Organization: